Experimental
Introduction
Selenium (Se) is an essential element for humans and other animals with a narrow adequate range between deficient and excessive doses, and has functions in antioxidant effect, 1 alleviating the toxicity of heavy metals, 2 and sperm production. 3 Se deficiency induces arterial sclerosis, 4 cardiac myopathy, 5 and infectious disease. 6 On the other hand, Se is known to be a highly toxic element, and Se excess leads to hair and nail loss as well as brittleness, gastrointestinal problem, and nervous system abnormalities. 7 Therefore, the recommended daily intake of Se for human health is strictly defined. 8 The metabolic pathway of Se, such as absorption, metabolism, and excretion, has been elucidated by studies of Se compounds related to human Se metabolism. 9, 10 Many tracer experiments with a stable Se isotope were performed to elucidate the metabolic pathway of Se. [11] [12] [13] Suzuki et al. revealed a metabolic pathway of selenite in the blood stream by Se speciation studies. 11, 12 Selenite taken up by red blood cells (RBCs) is reduced to selenide, and transferred to the liver in a form bound to albumin (Alb). Selenide is taken up by the liver, and is utilized for the synthesis of selenoproteins, such as selenoprotein P (Sel-P) and cellular glutathione peroxidase (cGPx). However, the metabolic fates of Sel-P and Se as Sel-P are not known. In addition, changes in a metabolic pathway of Se, such as absorption, metabolism, and excretion, under various Se nutritional statuses have not been investigated.
There are three major Se-containing proteins in human plasma: Sel-P, extra cellular GPx (eGPx), and selenium containing albumin (SeAlb).
14,15 Sel-P is the most common Secontaining protein in human plasma, and its concentration level is a good biochemical marker for Se status. 16, 17 A recent supplementation study found that Sel-P in plasma is a more accurate marker for Se saturation levels than the previously used eGPx. 18 Animal experiments using Sel-P-knockout mice revealed that Sel-P plays a pivotal role in delivering hepatic Se to target tissues, such as brain and testis. 19, 20 In order to investigate the transport of Se to tissues as Sel-P, it is important to measure the Se concentration in various organs.
Chromatographic separation coupled with ICPMS has been used for Se speciation analysis. 21 Sel-P speciation is studied by means of size-exclusion [11] [12] [13] and affinity chromatography. [22] [23] [24] One difficulty with conventional HPLC-ICPMS systems is that they require relatively large (sub-ml) sample volumes. In our previous work, it was possible to determine Sel-P in sub-ml samples of human plasma by coupling micro-affinity chromatography to ICPMS using a total consumption nebulizer. 25 To investigate the time-dependent metabolism of Se, which we called a "dynamic" pathway, 82 Se-enriched selenite was injected intravenously into mice, and endogenous and exogenous 82 Se in blood and twelve different organs were traced during whole the metabolic pathway, from 1 to 72 h after injection.
with 1 mol l -1 NaOH. 26 Samples were digested with nitric acid (70%) and hydrogen peroxide (30%) (both were of electronic laboratory grade, Kanto Chemical Co., Inc., Japan). The digested samples were diluted with ultrapure water (>18.4 MW cm -1 ) (Japan Millipore K.K., Tokyo, Japan). Standard solutions for calibration were prepared by diluting a standard solution of Se (1000 mg ml -1 ; AAS grade, Kanto Chemical Co., Inc., Japan) with 0.1 mol l -1 nitric acid. Indium (1000 mg ml -1 ; AAS grade, Kanto Chemical Co., Inc., Japan) was used as an internal standard. KCl and KBr (both are of suprapur, Merck Ltd., Darmstadt, Germany) were used to correct for spectral interferences. Oxalic acid (special reagent grade, Kanto Chemical Co., Inc., Japan) was used to correct for signal enhancement of Se due to carbon (C).
To validate the analytical procedures, we analyzed biological certified reference materials of NIST bovine liver CRM 1577a (National Institute of Standards and Technology, Gaithersburg, MD, USA), Seronorm ® trace elements human serum 203105 and seronorm ® trace elements human urine 201205 (Sero As, Bllingstad, Norway).
Buffer solutions for Se speciation were prepared by dissolving tris(hydroxymethyl)aminomethane (ultra grade, Sigma-Aldrich Japan K.K., Tokyo, Japan) in acetic acid (99.8%) and ammonia (29%) (both are of are special reagent grade, Kanto Chemical Co., Inc., Japan).
Animal experiments
Thirty male mice (Crlj: CD1(ICR)), 4 weeks old, were purchased from Charles River Laboratories Japan Inc. (Kanagawa, Japan), and had received a Se-adequate control diet (0.45 mg Se g ) for the following 4 weeks. These diets were purchased from Oriental Yeast Co., Ltd. (Tokyo, Japan).
After the 4-week feeding period, 0.2 ml of enriched solution (containing Na2 82 SeO3 as 11.25 mg Se ml -1 ) were injected intravenously into mice. Blood and twelve different organs (liver, kidneys, spleen, pancreas, heart, lungs, brain, thymus, submandibular glands, testes, epididymides, and seminal vesicles) were collected and weighted at the beginning of the mouse experiment (0), 1, 6, 24, or 72 h after injection. These organs are illustrated in Fig. 1 . Three samples of each group were collected. Liver perfusion was carried out with 5% glucose (special reagent grade, Wako Pure Chemical Industries, Ltd., Osaka, Japan).
Blood samples were heparinized and centrifuged at 1500g for 10 min at 4˚C, and separated into plasma and RBCs. RBCs were washed twice with 5% glucose. The hematocrit values were obtained from a small portion of a heparinized sample, which were used to calculate the volumes of both the plasma and RBCs.
Determination of total Se concentration in the mouse plasma, RBCs, and organs
To determine the total Se, an aliquot of plasma, RBCs, organs (about 0.1 g) were digested using a microwave oven (MLS-1200 MEGA; rotor, MDR-300/s; Milestone General, Tokyo, Japan) after the addition of 400 ml HNO3 and 200 ml H2O2. After samples were completely digested, indium was added to a final concentration of 50 ng ml -1 for use as an internal standard, and the weight was adjusted to 1.5 g (a dilution factor of 15) with ultra pure water.
Se and other elements (Mn, Cu, Zn, As) were determined with an ICPMS instrument (HP4500, Agilent Technologies Japan Ltd., Tokyo, Japan). In this case of determining total Se, a conventional nebulizer (AR35-1-FC1, Glass Expansion, West Melbourne, VIC, Australia) was used.
Since sample volumes were limited in this study, Se concentration in 100-ml samples was measured by flow injection ICPMS (FI-ICPMS). Carbon (C) concentration in the digested samples was determined by ICPAES (SPS5100, SII Nano Technology Inc., Tokyo, Japan) to correct for the enhancement effect due to co-existing organic carbon.
Determination of Sel-P and other proteins in mouse plasma
Prior to Se speciation analysis, the plasma was filtered through a 0.45-mm nitrocellulose membrane filter (Nihon Millipore K. K., Tokyo, Japan). We used a capillary liquid chromatographic system consisting of a degasser (DG661, GL Sciences Inc., Tokyo, Japan), a capillary pump (MP710i, GL Sciences Inc., Japan), and a sample injector (sample volume: 0.5 ml; Model C4-1344, Valco Instruments Co., Houston, TX, USA). In order to operate at a low flow rate (6 ml min -1 ), the micro affinity column, which packed by heparin, was scaled down to 0.5 mm i.d. ¥ 35 mm long (AFpak AHR-894, Showa Denko K.K., Tokyo, Japan). In the case of speciation analysis of Se, a total consumption nebulizer (CEI-100 CETAC, Omaha, NE, USA) was used. Fused-silica tubes (50 mm i.d., 375 mm o.d.; GL Sciences Inc., Tokyo, Japan) were used for all connections.
Sel-P in mouse plasma was determined using micro-affinity chromatography coupled with low-flow ICPMS, which was developed in our previous work. 25 This system enabled speciation analysis of Sel-P in sub-ml plasma samples. It has been reported that only Sel-P among all of the Se-containing proteins in plasma is selectively retained on heparin. 15, 22 Histidine residues, which are a constituent of the heparinbinding site of selenoprotein P, are important in the binding. 27 To elute the absorbed Sel-P, the mobile phase was switched from equilibration buffer (0.02 M Tris-HNO3; pH 7.4) to elution buffer (0.02 M Tris-HNO3 + 1.4 M ammonium acetate; pH 7.4) by a step gradient at 180 s. The chromatographic peaks were integrated, and calibrated relative to the signal of a standard selenite solution (100 ng ml -1 ) obtained by FI-ICPMS.
Results and Discussion

Validation of analytical procedures
To validate the analytical results, we analyzed a bovine liver (NIST CRM 1577a), human serum (STE 203105) and human urine (STE 201205). Biological samples include large amounts of inorganic salt, organic compounds, such as protein and amino acid, which induce spectral interferences due to the formation of polyatomic ions, non-spectral interferences due to matrix. In this study, the spectral interferences of 40 Se and 82 Se, respectively, were corrected for mathematically by interference correction factors (IFs). Solutions of Cl and Br were prepared with concentration matching to their levels in bovine liver (Cl 50 mg ml -1 , Br 0.05 mg ml -1 ), human serum (Cl 250 mg ml -1 , Br 0.05 mg ml -1 ), and human urine (Cl 250 mg ml -1 , Br 0.05 mg ml -1 ) after 15 times dilution. The solutions were measured daily for calibrating IFs as described elsewhere. 28 In the case of bovine liver, correction equations are expressed as follows: 
Standard solutions of 20 ng ml -1 Se, 200 ng ml -1 Mn, Cu, Zn, As in 0, 1000, 2000 mg ml -1 C were used for the matrix effect on the analyte signal. The ratios of the Se signal enhancement were calculated in each level of the C concentration, are plotted in Fig. 2 . Since the Se intensity ratio proportionally increased along with an increase in the C concentration, it was decided that the Se signal enhancement needed to be corrected. In order to determine the signal enhancement correction factors (SFs), the C in digested samples was determined by using FI-ICPAES. The Se signal enhancement was corrected for mathematically by SFs obtained from the C concentration in each digested sample. In the case of bovine liver, the correction equations are expressed as follows: Finally, the analytical value was determined using an internalstandard method.
The results of a CRM analysis are summarized in Table 1; the concentrations of  77 Se and   82 Se agreed well with the certified values within the analytical error. These results confirmed that the ICPMS method used was suitable for the determination of Se in biological samples.
Calculation of endogenous and exogenous Se
In mice, Se isotopes (74, 76, 77, 78, 80, and 82) exist in their natural abundances (Fig. 3a) . After the intravenous injection of 82 Se-enriched selenite, exogenous and endogenous Se were distributed throughout the mouse body (Fig. 3b) 
Distribution of endogenous and exogenous 82 Se in mouse organs, RBCs, and plasma under different Se nutritional statuses
The concentrations of C in digested organs, RBCs, and plasma were measured by FI-ICPAES, and the results were 1200 -6900 mg ml -1 , 3600 mg ml -1 , 1400 mg ml -1 , respectively. SFs were calculated from both data shown in Fig. 2 , and the concentration of C in digested samples. Spectral interferences and the signal enhancement due to organic carbon were corrected for as mentioned in the previous section. After performing internal standardization, endogenous and exogenous 82 Se were At the beginning of tracer experiment (Figs. 4a and 5a ), endogenous 82 Se in the liver of mice fed the Se-deficient diet was 3 times less than those of mice fed the control diet. The lack of Se in the liver resulted in a lowering of endogenous 82 Se in the kidneys, RBCs, and plasma of mice fed the deficient diet. Considering that Se absorbed in the liver is utilized for the synthesis of Sel-P and cGPx, 9 the decreased hepatic Se concentration in mice fed the deficient diet likely reflects the insufficient supply of Se, and is consistent with the decreased levels of Se circulating in the mouse body. However, this reduction of endogenous 82 Se in the testis and epididymis was relatively small compared with that of other organs. Since Se plays an important role in sperm production, 3 we assume that some metabolic pathways work to maintain the Se concentration. As shown in Fig. 4 , exogenous 82 Se was mainly distributed in the liver, kidney, RBCs, and plasma during the experiment period. The exogenous 82 Se dramatically increased in liver during the first hour following injection. The injected Se was absorbed by the liver more efficiently than by other organs, and was supposed to be utilized for the synthesis of selenoproteins, or to be excreted from the mouse body. On the other hand, the distribution of exogenous 82 Se was observed in almost all other organs at 1 h after injection. It is likely that there is another pathway whereby the injected 82 Se-enriched selenite is transferred to other organs without passing through the liver. Exogenous 82 Se absorbed in the organs of mice fed the control diet steadily decreased from 1 to 72 h after injection, and the relative Se distribution recovered to that observed at the beginning of the experiment. The excess Se was excreted from the mouse body because sufficient Se was present in the mice As shown in Fig. 5 , at 1 h after injection, the distribution of exogenous 82 Se in the liver of mice fed the deficient diet was observed to be at the same level as that of mice fed the control diet. Almost of the injected 82 Se-enriched selenite was initially absorbed in the liver regardless of the Se nutritional status. At 6 h after injection, the decrease of exogenous 82 Se in mice fed the deficient diet was less than that in mice fed the control diet, and the amount of exogenous 82 Se in organs remained higher than that in mice fed the control diet. We assume that the excretion of Se was suppressed, and the Se level was maintained in each organ.
The variation of endogenous and exogenous
82
Se in liver, kidney, RBCs, and plasma, was plotted against time for Seadequate and -deficient statuses (Fig. 6) . From 1 to 6 h after injection, exogenous 82 Se in the livers and kidneys of mice fed the control diet dramatically decreased (Figs. 6a and 6b) , whereas that in mice fed the deficient diet remained constant (Figs. 6e and 6f) . The absorption of exogenous 82 Se into the blood stream of mice fed the deficient diet was higher than that in mice fed the control diet. In particular, at 6 h after injection, the amount of Se was 2.5 times as much as that in mice fed the control diet (Figs. 6d and 6h) . We assume that the amount of Se in the plasma increased in the deficient mice so that Se could be supplied to other organs.
Investigation of dynamic pathways of Se species in mouse plasma
To elucidate the dynamic pathways of Se species in plasma, we analyzed Se speciation by means of micro-affinity chromatography coupled with low-flow ICPMS. As shown in Fig. 7 , two Se peaks were observed in the plasma of mice fed the deficient diet. The first peak, which was not absorbed by heparin, corresponds to Se-containing proteins other than Sel-P (SeAlb and eGPx), and the second peak, which was eluted by switching from equilibration buffer to elution buffer, corresponds to Sel-P. At 1 h after injection (Fig. 7a) , exogenous 82 Se was mainly distributed to Se-containing proteins other than Sel-P. However at 6 h after injection (Fig. 7b) , exogenous 82 Se was distributed to Sel-P.
As shown in Figs. 8a and 8b, in plasma of mice fed the control diet, exogenous 82 Se of Se-containing proteins other than Sel-P peaked at 1 h after injection, and quickly decreased from 1 to 6 h after injection, whereas exogenous 82 Se of Sel-P peaked at 6 h after injection and gradually decreased from 6 to 72 h after injection. Suzuki and Itoh reported that 82 Se enriched selenite was mainly combined with Alb at 10, 30, and 60 min after injection. 11 Thus, we suspected that Se-containing proteins other than Sel-P observed at 1 h after injection consisted mainly of SeAlb. These results suggest that almost all of the 82 Seenriched selenite was transformed into SeAlb within 1 h, and was absorbed by the liver, where Sel-P in mouse plasma was synthesized within 6 h. There are two pathways whereby Se was transferred to organs; one was as SeAlb until 1 h after injection, and the other was as Sel-P from 6 to 72 h.
As shown in Figs. 8c and 8d, in mice fed the deficient diet, the increase of exogenous 82 Se as Se-containing proteins other than Sel-P was almost comparable to that in mice fed the control diet, although about a 1.5-times increase of exogenous 82 Se as Sel-P was observed compared with mice fed the control diet. It was reported that Sel-P mRNA in Se deficiency remained higher relative to the control. 29 Their finding agreed with our results that Sel-P was produced more efficiently in Se deficiency than the control. As shown in Fig. 5 , the experimental results that exogenous 82 Se in organs remained higher than that in mice fed the control diet could be explained by the continuous supply of Se as a chemical form of Sel-P in plasma from 6 to 72 h after injection. It is suspected that Sel-P plays an important role in Se transport to organs.
Conclusions
Most 82 Se-enriched selenite was transferred to the liver within 1 h after intravenous injection, and was utilized for the synthesis of selenoproteins, regardless of the Se nutrition status. We suspect that 82 Se-enriched selenite was transformed into SeAlb within 1 h, and was mainly absorbed by the liver, where Sel-P was produced within 6 h. Sel-P gradually decreased from 6 to 72 h as Se was transported to other organs. These results suggest that there are two pathways for Se metabolism in mice. One is a pathway for Se transfer in the chemical form SeAlb until 1 h after injection; and the other is a pathway for Se transfer in the chemical form Sel-P, from 6 to 72 h. Because the exogenous 82 Se in the plasma of mice fed the deficient diet increased in the chemical form Sel-P to 1.5 times high as much as that of mice fed the control diet, it appears that Sel-P played an important role in the transport of Se to Se-deficient organs.
